Microfluidics-based bioprinting

  • Founded in 2012 as a spin-off from Chalmers University of Technology in Sweden, Fluicell is a public biotech company providing platforms to investigate cell behavior like never before. The company is a world leader and pioneer in open-volume microfluidics for the life sciences, and holds a strong IP and patent position with five different patent families in the estate.

    The company has commercialised a product portfolio to study individual cells, primarily in the field of drug development and cell biology.